OUTCOME RELIABILITY IN NON-AMBULATORY BOYS/MEN WITH DUCHENNE MUSCULAR DYSTROPHY

被引:61
作者
Connolly, Anne M. [1 ,2 ]
Malkus, Elizabeth C. [1 ]
Mendell, Jerry R. [3 ,4 ]
Flanigan, Kevin M. [3 ,4 ]
Miller, J. Philip [5 ]
Schierbecker, Jeanine R. [1 ]
Siener, Catherine A. [1 ]
Golumbek, Paul T. [1 ,2 ]
Zaidman, Craig M. [1 ,2 ]
McDonald, Craig M. [6 ]
Johnson, Linda [6 ]
Nicorici, Alina [6 ]
Karachunski, Peter I. [7 ]
Day, John W. [8 ]
Kelecic, Jason M. [8 ]
Lowes, Linda P. [3 ,4 ]
Alfano, Lindsay N. [3 ,4 ]
Darras, Basil T. [9 ]
Kang, Peter B. [10 ]
Quigley, Janet [9 ]
Pasternak, Amy E. [9 ]
Florence, Julaine M. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[3] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA
[4] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH USA
[5] Washington Univ, Sch Med, Dept Biostat, St Louis, MO 63110 USA
[6] Univ Calif Davis, Med Ctr, Dept Phys Med & Rehabil, Sacramento, CA 95817 USA
[7] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA
[8] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA
[9] Harvard Univ, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA
[10] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA
基金
美国国家卫生研究院;
关键词
corticosteroids; Duchenne muscular dystrophy; non-ambulatory; pulmonary function; quality of life; strength; HAND FUNCTION; NEUROMUSCULAR DISEASE; MUSCLE STRENGTH; CHILDREN; VALIDATION; SCOLIOSIS; SURVIVAL; TRIALS; SLEEP;
D O I
10.1002/mus.24346
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Therapeutic trials in Duchenne muscular dystrophy (DMD) often exclude non-ambulatory individuals. Here we establish optimal and reliable assessments in a multicenter trial. Methods: Non-ambulatory boys/men with DMD (N=91; 16.7 +/- 4.5 years of age) were assessed by trained clinical evaluators. Feasibility (percentage completing task) and reliability [intraclass correlation coefficients (ICCs) between morning and afternoon tests] were measured. Results: Forced vital capacity (FVC), assessed in all subjects, showed a mean of 47.8 +/- 22% predicted (ICC 0.98). Brooke Upper Extremity Functional Rating (Brooke) and Egen Klassifikation (EK) scales in 100% of subjects showed ICCs ranging from 0.93 to 0.99. Manual muscle testing, range of motion, 9-hole peg test, and Jebsen-Taylor Hand Function Test (JHFT) demonstrated varied feasibility (99% to 70%), with ICCs ranging from 0.99 to 0.64. We found beneficial effects of different forms of corticosteroids for the Brooke scale, percent predicted FVC, and hand and finger strength. Conclusions: Reliable assessment of non-ambulatory boys/men with DMD is possible. Clinical trials will have to consider corticosteroid use. Muscle Nerve 51: 522-532, 2015
引用
收藏
页码:522 / 532
页数:11
相关论文
共 53 条
[1]   Correlations of Egen Klassifikation and Barthel Index scores with pulmonary function parameters in Duchenne muscular dystrophy [J].
Afonso Brunherotti, Marisa ;
Sobreira, Claudia ;
Luiz Rodrigues-Junior, Antnio ;
Renato de Assis, Marcos ;
Terra Filho, Joao ;
Baddini Martinez, Jose Antonio .
HEART & LUNG, 2007, 36 (02) :132-139
[2]   Steroid treatment and the development of scoliosis in males with Duchenne muscular dystrophy [J].
Alman, BA ;
Raza, SN ;
Biggar, WD .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2004, 86A (03) :519-524
[3]   RELIABILITY OF GONIOMETRIC MEASUREMENTS [J].
BOONE, DC ;
AZEN, SP ;
LIN, CM ;
SPENCE, C ;
BARON, C ;
LEE, L .
PHYSICAL THERAPY, 1978, 58 (11) :1355-1360
[4]   HYPOXANTHINE AND MCARDLE DISEASE - A CLUE TO METABOLIC STRESS IN THE WORKING FOREARM [J].
BROOKE, MH ;
PATTERSON, VH ;
KAISER, KK .
MUSCLE & NERVE, 1983, 6 (03) :204-206
[5]   DUCHENNE MUSCULAR-DYSTROPHY - PATTERNS OF CLINICAL PROGRESSION AND EFFECTS OF SUPPORTIVE THERAPY [J].
BROOKE, MH ;
FENICHEL, GM ;
GRIGGS, RC ;
MENDELL, JR ;
MOXLEY, R ;
FLORENCE, J ;
KING, WM ;
PANDYA, S ;
ROBISON, J ;
SCHIERBECKER, J ;
SIGNORE, L ;
MILLER, JP ;
GILDER, BF ;
KAISER, KK ;
MANDEL, S ;
ARFKEN, C .
NEUROLOGY, 1989, 39 (04) :475-481
[6]   Motor assessment in patients with Duchenne muscular dystrophy [J].
Campolina Diniz, Gabriela Palhares ;
Belizario Facury Lasmar, Laura Maria de Lima ;
Giannetti, Juliana Gurgel .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (06) :416-421
[7]   Myostatin does not regulate cardiac hypertrophy or fibrosis [J].
Cohn, Ronald D. ;
Liang, Hsin-Yueh ;
Shetty, Reena ;
Abraham, Theodore ;
Wagner, Kathryn R. .
NEUROMUSCULAR DISORDERS, 2007, 17 (04) :290-296
[8]  
Connolly Anne M, 2013, J Bone Joint Surg Am, V95, pe86, DOI 10.2106/JBJS.M.00428
[9]  
Davis Sarah E, 2010, J Clin Neuromuscul Dis, V11, P97, DOI 10.1097/CND.0b013e3181c5053b
[10]   IPPB-assisted coughing in neuromuscular disorders [J].
Dohna-Schwake, Christian ;
Ragette, Regine ;
Teschler, Helmut ;
Voit, Thomas ;
Mellies, Uwe .
PEDIATRIC PULMONOLOGY, 2006, 41 (06) :551-557